Company registration number 12531892 (England and Wales)
HELIOS SHIELD LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
HELIOS SHIELD LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
HELIOS SHIELD LTD
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
3
119,963
113,696
Current assets
Debtors
4
42,583
6,280
Cash at bank and in hand
513
737
43,096
7,017
Creditors: amounts falling due within one year
5
(216,674)
(149,706)
Net current liabilities
(173,578)
(142,689)
Net liabilities
(53,615)
(28,993)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(53,715)
(29,093)
Total equity
(53,615)
(28,993)

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 26 June 2025 and are signed on its behalf by:
R Gagne
Director
Company registration number 12531892 (England and Wales)
HELIOS SHIELD LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -
1
Accounting policies
Company information

Helios Shield Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 73 Cornhill, London, EC3V 3QQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
Straight line over 9 years
Development costs
Straight line over 10 years
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

HELIOS SHIELD LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 3 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

HELIOS SHIELD LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 4 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
-
0
-
0
HELIOS SHIELD LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 5 -
3
Intangible fixed assets
Other
£
Cost
At 1 April 2023
145,104
Additions
27,077
At 31 March 2024
172,181
Amortisation and impairment
At 1 April 2023
31,408
Amortisation charged for the year
20,810
At 31 March 2024
52,218
Carrying amount
At 31 March 2024
119,963
At 31 March 2023
113,696
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
42,583
6,280
5
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
-
0
511
Taxation and social security
272
192
Other creditors
216,402
149,003
216,674
149,706
6
Related party transactions

Included in other creditors is an amount of £212,938 (2023: £145,538) due from a company under common control. This balance is interest free and repayable on demand.

 

Included in other debtors is an amount of £39,968 (2023: £3,960) due from related participators. There are no terms to interest or repayment on this balance.

 

HELIOS SHIELD LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 6 -
7
Directors' transactions

Included in other debtors is an amount of £455 (2023: £240) due from the directors. There are no terms to interest or repayment on this amount.

 

2024-03-312023-04-01falsefalsefalse26 June 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityJ CumminR PrasadM GagneR Gagne125318922023-04-012024-03-31125318922024-03-31125318922023-03-3112531892core:IntangibleAssetsOtherThanGoodwill2024-03-3112531892core:IntangibleAssetsOtherThanGoodwill2023-03-3112531892core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3112531892core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3112531892core:CurrentFinancialInstruments2024-03-3112531892core:CurrentFinancialInstruments2023-03-3112531892core:ShareCapital2024-03-3112531892core:ShareCapital2023-03-3112531892core:RetainedEarningsAccumulatedLosses2024-03-3112531892core:RetainedEarningsAccumulatedLosses2023-03-3112531892bus:Director42023-04-012024-03-3112531892core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112531892core:PatentsTrademarksLicencesConcessionsSimilar2023-04-012024-03-3112531892core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-04-012024-03-31125318922022-04-012023-03-3112531892core:IntangibleAssetsOtherThanGoodwill2023-03-3112531892core:WithinOneYear2024-03-3112531892core:WithinOneYear2023-03-3112531892bus:PrivateLimitedCompanyLtd2023-04-012024-03-3112531892bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3112531892bus:FRS1022023-04-012024-03-3112531892bus:AuditExemptWithAccountantsReport2023-04-012024-03-3112531892bus:Director12023-04-012024-03-3112531892bus:Director22023-04-012024-03-3112531892bus:Director32023-04-012024-03-3112531892bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP